The role of selected nutraceuticals in management of prediabetes and diabetes: An updated review of the literature.
Phytother Res
; 36(10): 3709-3765, 2022 Oct.
Article
en En
| MEDLINE
| ID: mdl-35912631
ABSTRACT
Dysglycemia is a disease state preceding the onset of diabetes and includes impaired fasting glycemia and impaired glucose tolerance. This review aimed to collect and analyze the literature reporting the results of clinical trials evaluating the effects of selected nutraceuticals on glycemia in humans. The results of the analyzed trials, generally, showed the positive effects of the nutraceuticals studied alone or in association with other supplements on fasting plasma glucose and post-prandial plasma glucose as primary outcomes, and their efficacy in improving insulin resistance as a secondary outcome. Some evidences, obtained from clinical trials, suggest a role for some nutraceuticals, and in particular Berberis, Banaba, Curcumin, and Guar gum, in the management of prediabetes and diabetes. However, contradictory results were found on the hypoglycemic effects of Morus, Ilex paraguariensis, Omega-3, Allium cepa, and Trigonella faenum graecum, whereby rigorous long-term clinical trials are needed to confirm these data. More studies are also needed for Eugenia jambolana, as well as for Ascophyllum nodosum and Fucus vesiculosus which glucose-lowering effects were observed when administered in combination, but not alone. Further trials are also needed for quercetin.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Estado Prediabético
/
Intolerancia a la Glucosa
/
Curcumina
/
Diabetes Mellitus
/
Diabetes Mellitus Tipo 2
Idioma:
En
Revista:
Phytother Res
Año:
2022
Tipo del documento:
Article
País de afiliación:
Italia